ER positive breast cancer: Screening for clinical variables to predict late distance disease recurrence

Predicting late breast cancer recurrence with screening assays

The SOFT trial: Comparing adjuvant tamoxifen with ovarian function suppression via exemestane to tamoxifen alone

How can scalp-cooling reduce chemotherapy induced hair loss?

Two years of extended anastrozole therapy as effective as five

Acupuncture significantly reduces joint pain for breast cancer patients

HER2low invasive breast cancer: Trastuzumab offers no improvement for invasive disease free survival

Adjuvant trastuzumab did not improve outcomes for patients with HER2-low breast cancer

Increasing the dose intensity of chemotherapy may lower the risk of breast cancer recurrence and death

The importance of data connectivity and e-health

A world wide web for genomic data

Personalised medicine for inherited breast cancer